TRIS(2-CHLOROETHYL) PHOSPHATE PHARMACOKINETICS IN THE FISCHER-344 RAT- A COMPARISON OF CONVENTIONAL METHODS AND IN-VIVO MICRODIALYSIS COUPLED WITH TANDEM MASS-SPECTROMETRY
K. Dix et al., TRIS(2-CHLOROETHYL) PHOSPHATE PHARMACOKINETICS IN THE FISCHER-344 RAT- A COMPARISON OF CONVENTIONAL METHODS AND IN-VIVO MICRODIALYSIS COUPLED WITH TANDEM MASS-SPECTROMETRY, Journal of pharmaceutical sciences, 83(11), 1994, pp. 1622-1629
The pharmacokinetics of tris(2-chloroethyl) phosphate (TRCP, 20 mg/kg,
iv) were investigated in awake male and female and anesthetized male
Fischer 344 (F344) rats by conventional (CONV) sampling/detection meth
ods (blood withdrawal with sample workup and analysis for TRCP). TRCP
pharmacokinetics were also investigated in anesthetized male F344 rats
using a new sampling/detection technique, in vivo microdialysis coupl
ed with tandem mass spectrometry(1) (MD/MS/MS). The concentration of f
ree TRCP in plasma versus time profiles were analyzed using noncompart
mental methods to estimate pharmacokinetic parameters. Comparisons of
mean parameter estimates were made for (1) awake males versus females
in CONV studies (t test, no significant differences, p less than or eq
ual to 0.05) and (2) awake and anesthetized males in CONV studies and
anesthetized males in MD/MS/MS studies. There were significant differe
nces (Scheffe's test) for the three groups of male rats, most notably
the free TRCP concentration in plasma at early time points in CONV ver
sus MD/MS/MS studies. The contributions of an indwelling jugular cannu
la, the blood sampling regimen, and the in vitro MD/MS/MS standard cal
ibration curve were investigated. It appears that quantitation of TRCP
by mass spectrometry using an in vitro standard calibration is respon
sible for the difference.